同步结肠癌的长期存活结果:基于跨区域人口的比较分析
Eva Rademaker1,2, Bade C Aktas2, Petur Snaebjornsson3,4
1Department of Surgery, Isala, Zwolle, the Netherlands.
Diseases of the colon and rectum
|November 18, 2025
概括
同步结肠癌,同时或在六个月内诊断,与单独的瘤相比,不会显著影响长期生存率. 这一发现适用于各种阶段和瘤位置,为患者的治疗结果提供了关键的见解.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 临床研究 临床研究
背景情况:
- 同步性结肠癌涉及两个或两个以上初级结肠癌同时或在六个月内被诊断出来.
- 这种情况占所有结肠癌诊断的3 - 5% .
- 虽然术后发病率可能会增加,但长期生存的影响仍然不清楚.
研究的目的:
- 与单一瘤相比,评估同步结肠癌对无病和整体存活率的影响.
- 通过瘤侧面性和阶段分层的子组分析生存差异.
主要方法:
- 这是一项回顾性,观察性,多中心,基于人口的研究,涉及50家荷兰医院.
- 包括患有I-III期结肠癌的患者,接受治疗性瘤切除 (2014-2015).
- 随访数据收集到2024年6月,随访时间中位数为60.1个月.
主要成果:
- 包括7982名患者;269名 (3.4%) 患有同步结肠瘤.
- 单一结肠癌和同步结肠癌之间的5年无病生存率 (70.0%与65.7%) 或整体生存率 (75.5%与72.4%) 没有显著差异.
- 在不同阶段和单边/双边或右/左主导同步瘤之间,生存结果相似.
结论:
- 与单一瘤相比,同步结肠癌不会显著影响长期无病或整体存活率.
- 根据瘤位置和阶段的亚组分析也显示没有显著的生存差异.
- 该研究的回顾性质是一个值得注意的局限性.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
475
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.9K
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Comparing the Survival Analysis of Two or More Groups
541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541
Actuarial Approach
280
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
280
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
